— Know what they know.
Not Investment Advice

ORKA NASDAQ

Oruka Therapeutics, Inc.
1W: -8.2% 1M: -15.8% 3M: +81.5% YTD: +107.6% 1Y: +452.6% 3Y: +335.1% 5Y: +181.5%
$60.61
+1.92 (+3.27%)
 
Weekly Expected Move ±10.4%
$49 $55 $62 $68 $75
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 30 · $2.3B mcap · 26M float · 5.30% daily turnover · Short 55% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$-116M
Net Income
-10.4% YoY
$-91M
Free Cash Flow
-17.8% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-27.2%
ROA-26.3%
ROIC-77.0%

Valuation

P/E-28.8
P/B6.9
EV/EBITDA-18.9

Leverage

Debt/Equity0.00
Current Ratio22.37
Interest Cov.0.0x

Quality Scores

Piotroski F3/9
Altman Z96.72
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms